epinephrine; lidocaine hydrochloride · Fresenius Kabi Usa · NDA 006488, 010418
Xylocaine W/ Epinephrine
Earliest generic entry, as listed · earliest of 6 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 10
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 006488 · 003 · RLD · discontinued | injectable, injection | 0.01MG/ML;2% | open |
| 006488 · 004 · RLD | injectable, injection | 0.01MG/ML;1% | open |
| 006488 · 005 · RLD | injectable, injection | 0.02MG/ML;2% | open |
| 006488 · 012 · RLD | injectable, injection | 0.005MG/ML;0.5% | open |
| 006488 · 017 · RLD | injectable, injection | 0.005MG/ML;1.5% | open |
| 006488 · 018 · RLD | injectable, injection | 0.005MG/ML;1% | open |
| 006488 · 019 · RLD | injectable, injection | 0.005MG/ML;2% | open |
| 010418 · 006 · discontinued | injectable, injection | 0.005MG/ML;1% | open |
| 010418 · 008 · discontinued | injectable, injection | 0.005MG/ML;2% | open |
| 010418 · 010 · discontinued | injectable, injection | 0.005MG/ML;1.5% | open |